{
    "code": "02021625",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021625",
    "time": "2016-08-05 04:16:03",
    "許可證字號": "衛署藥輸字第021625號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "106\/04\/08",
    "發證日期": "86\/04\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "null",
    "中文品名": "丁基原啡因舌下錠０．２毫克",
    "英文品名": "TEMGESIC SUBLINGUAL TABLETS 0.2MG",
    "適應症": "中、重度疼痛。",
    "劑型": "118舌下錠",
    "包裝": "6-1000粒(PVC\/PVdc)盒裝 6-1000粒(nylon\/Al\/uPVC)盒裝 6-1000粒(HDPE)瓶裝",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "C第三級管制藥品",
    "主成分略述": "BUPRENORPHINE (AS HYDROCHLORIDE)",
    "限制項目": [
        "02輸入",
        "06管制藥品",
        "33第三級管制藥品"
    ],
    "申請商名稱": "1225201100  裕利股份有限公司",
    "申請商地址": "台北市松山區南京東路四段126號10樓，10樓之1-3",
    "主製造廠": {
        "製造廠名稱": "F130089000  RECKITT BENCKISER HEALTHCARE (UK) LIMITED",
        "製造廠廠址": "DANSOM LANE, HULL, EAST YORKSHIRE, UNITED KINGDOM, HU8 7DS",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED KINGDOM",
        "製程": ""
    },
    "CCC號列": "30044019001 其他麻醉藥品製劑Other narcotics preparations",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F130379000  Indivior UK Limited",
            "製造廠廠址": "103 - 105 Bath Road, Berkshire England, SL1 3UH",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": ""
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2808801520",
            "成分名稱": "BUPRENORPHINE (AS HYDROCHLORIDE)",
            "含量描述": "(0.216)",
            "含量": "0.2000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "L",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "圖片",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=430&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Temgesic Tab._PI (第二階段)-105-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=001&Type=9"
        },
        {
            "title": "Temgesic Tab PI(ZP MAH+excipients)-104-11-19(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=008&Type=9"
        },
        {
            "title": "Temgesic Tab._Carton (第二階段)-105-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=005&Type=8"
        },
        {
            "title": "Temgesic Tab._PI (第二階段)-105-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=004&Type=8"
        },
        {
            "title": "Temgesic Tablet_Blister-105-06-23.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=003&Type=8"
        },
        {
            "title": "20141202 Temgesic Tab_Packaging Reissue_TFDA approved packaging-104-09-15(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=020&Type=8"
        },
        {
            "title": "Tem tab_Chinese label-104-09-15(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=019&Type=8"
        },
        {
            "title": "Tem tab_Outer Box-104-09-15(廠商自行上傳).pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=018&Type=8"
        },
        {
            "title": "Tem tab_Outer Box-103-11-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=002&Type=8"
        },
        {
            "title": "Tem tab_Chinese label-103-11-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021625&Seq=001&Type=8"
        }
    ]
}